Business
Vivos Therapeutics to Present at Upcoming SLEEP 2022 Annual Meeting
HIGHLANDS RANCH, Colo., May 26, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or the “Company”), a medical technology company
About this update from Vivos Therapeutics, Inc.
[{"type":"text","content":"HIGHLANDS RANCH, Colo., May 26, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ: VVOS) (“Vivos” or the “Company”), a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment modalities for patients with dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, today announced that the Company will give two presentations at SLEEP 2022, the annual meeting of the Associated Professional Sleep Societies (APSS), which is a joint venture of the American Academy of Sleep Medicine (AASM) and Sleep Research Society (SRS). The conference will take place in Charlotte, N.C., on June 4 through 8, 2022. Dr. Seth Heckman, Vivos Medical Advisory Board member, will present an abstract on a retrospective study with Vivos patients titled, “Non-Surgical Maxillary Expansion Using A Novel Oral Appliance System,” during a poster session on June 6 at 5:15 p.m. ETDr. J. Steven Alexander, a molecular physiologist working on the cellular mechanisms underlying maxillary modeling in adults with OSA, will discuss the basic science behind The Vivos Method during a symposium chaired by Dr. Clete Kushida, Vivos Medical Advisory Board Co-Chair, titled, “How New and Emerging Technologies Will Shape the Future of Sleep and Circadian Medicine,” on June 8 at 3:15 p.m. ET The presentation at SLEEP 2022 is a part of Vivos’ continuing efforts to generate and publish research and other data demonstrating how The Vivos Method can address dentofacial abnormalities and/or mild to moderate OSA and snoring in adults. SLEEP 2022 provides evidence-based education to advance sleep medicine’s science and clinical practice, disseminating sleep and circadian research, promoting basic science translation into clinical practice and more. Thousands of sleep medicine experts from around the world attend the conference each year. About Vivos Therapeutics, Inc. Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults. The Vivos Method represents the first clinically effective non-surgical, non-invasive, non-pharmaceutical and cost-effective solution...